CELZ Creative Medical Technology Holdings, Inc.

$1.22

Creative Medical Technology Holdings, Inc. (CELZ) is expected to report earnings on November 6, 2026, before the market open. The consensus earnings estimate is a loss of $0.24 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -17.0% since its last earnings release on August 7, 2026.

Creative Medical Technology Missed Consensus Estimates
Friday, August 7, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 6
Friday · Before Open
Earnings Whisper
-
vs ($0.24)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.39

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings Inc. is a commercial stage biotechnology company focused on a regenerative approach to Immunotherapy, Urology, Neurology and Orthopedics. Creative Medical Technology Holdings Inc. is based in PHOENIX.

Sector

Healthcare

Industry

Biotechnology